GRACE :: Head/Neck Cancer
Denise Brock

ASCO 2017 – Head and Neck Cancer – Cisplatin with Radiation, Toxicity Problems with the Standard Regimen


Dr. Jared Weiss, University of North Carolina School of Medicine

Dr. Siddharth Sheth, University of North Carolina

Joshua Bauml, MD, University of Pennsylvania


Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and Siddharth Sheth, Hematology Oncology Fellow at the University of North Carolina, gathered post meeting to discuss new information from ASCO 2017 regarding head and neck cancers.   In this roundtable video, the doctors discuss Cisplatin with Radiation, Toxicity Problems with the Standard Regimen.


 

 

 


 Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

  

     

 

 

 

 

 

 


Denise Brock

ASCO 2017 – Head and Neck Cancer – Alternatives to Every Three Week Cisplatin Currently Used in Practice, Weekly Cisplatin & Cetuximab


Dr. Jared Weiss, University of North Carolina School of Medicine

Dr. Siddharth Sheth, University of North Carolina

Joshua Bauml, MD, University of Pennsylvania


Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, and Siddharth Sheth, Hematology Oncology Fellow at the University of North Carolina, gathered post meeting to discuss new information from ASCO 2017 regarding head and neck cancers.   In this roundtable video, the doctors discuss Alternatives to Every Three Week Cisplatin Currently Used in Practice, Weekly Cisplatin & Cetuximab.


 

 

 


 Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

  

     

 

 

 

 

 

 


Denise Brock

Head and Neck Cancer Treatment Update: Pembrolizumab, Nivolumab and PD-L1 Markers

Dr. Jared Weiss, University of North Carolina School of Medicine

Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.

Joshua Bauml, MD, University of Pennsylvania

  

 


 Please feel free to offer comments and raise questions in our Discussion Forums.


 

 


Denise Brock

The Role of HPV in Head and Neck Cancers Webinar Series: Does the HPV vaccine protect against head and neck cancer?

The Role of HPV in Head and Neck Cancers Webinar Series: Does the HPV vaccine protect against head and neck cancer?

We are pleased to present the 6th and final video in this webinar series – The Role of HPV in Head and Neck Cancers Webinar Series: Does the HPV vaccine protect against head and neck cancer? with Dr. Chera.   Bhisham Chera, MD, is a UNC Lineberger Comprehensive Cancer Center member and Assistant Professor in the Department of Radiation Oncology in the Clinical Division at UNC-Chapel Hill.  

 


 

 

See more from this series at http://cancergrace.org/hnscc/the-role-of-hpv-in-head-and-neck-cancers/

 

Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

 

 

       

 

 

 

 

 


Denise Brock

The Role of HPV in Head and Neck Cancers Webinar Series: Current treatments and most promising clinical trials for head and neck cancer

The Role of HPV in Head and Neck Cancers Webinar Series: Current treatments and most promising clinical trials for head and neck cancer.

Recently Dr. Bhisham S. Chera joined GRACE to discuss the role of HPV in head and neck cancers. Bhisham Chera, MD, is a UNC Lineberger Comprehensive Cancer Center member and Assistant Professor in the Department of Radiation Oncology in the Clinical Division at UNC-Chapel Hill.   We are pleased to present the 5th video in this webinar series – The Role of HPV in Head and Neck Cancers: Current treatments and most promising clinical trials for head and neck cancer.

 


 

See more from this series at http://cancergrace.org/hnscc/the-role-of-hpv-in-head-and-neck-cancers/

 

Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

 

 

       

 

 

 

 

 


Ask Us, Q&A
Head/Neck Cancer Expert Content

Archives

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243